Vaccine distribution could possibly start in late November
If Pfizer's vaccine is authorized by the FDA, U.S. distribution could start at increments of about 20 million doses per month, potentially as early as late November, Secretary of Health and Human Services Alex Azar told reporters Tuesday.
"Back in April, when I was forming Operation Warp Speed, if you told me that by November we would have exciting data from a Phase 3 vaccine trial and substantial supplies of a monoclonal antibody authorized and ready for distribution, I would have been absolutely stunned," Azar said.
Pfizer said Monday that the earliest it could have the requisite safety data needed to apply for FDA authorization is the third week of November. The company also said it expects to produce 50 million doses globally before the end of the year. Each person needs two doses.
ABC News' Sony Salzman contributed to this report







